QSAM
Price:
$8.3
Market Cap:
$18.44K
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.
Industry
Biotechnology
IPO Date
2012-08-13
Stock Exchange
OTC
Ticker
QSAM
According to QSAM Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.91. This represents a change of 1.96% compared to the average of -4.82 of the last 4 quarters.
The mean historical PE Ratio of QSAM Biosciences, Inc. over the last ten years is -1.47. The current -4.91 PE Ratio has changed 33.23% with respect to the historical average. Over the past ten years (40 quarters), QSAM's PE Ratio was at its highest in in the December 2019 quarter at 25.61. The PE Ratio was at its lowest in in the December 2023 quarter at -11.37.
Average
-1.47
Median
-0.02
Minimum
-8.51
Maximum
-0.00
Discovering the peaks and valleys of QSAM Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.78%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -99.95%
Minimum Annual PE Ratio = -8.51
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -4.90 | 297.65% |
| 2022 | -1.23 | 10.94% |
| 2021 | -0.01 | -57.16% |
| 2020 | -0.03 | -99.69% |
| 2019 | -8.51 | 17.45% |
| 2018 | -0.05 | 289.78% |
| 2017 | -0.00 | 13.15% |
| 2016 | -0.00 | 1.37% |
| 2015 | -0.00 | 63.79% |
| 2015 | -0.00 | -99.95% |
The current PE Ratio of QSAM Biosciences, Inc. (QSAM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.05
5-year avg
-2.94
10-year avg
-1.47
QSAM Biosciences, Inc.’s PE Ratio is less than NutraLife BioSciences, Inc. (-0.00), less than Cantabio Pharmaceuticals, Inc. (0), less than Humanigen, Inc. (0), less than Rapid Therapeutic Science Laboratories, Inc. (-0.01), less than Hempfusion Wellness Inc. (0), less than NMC Health plc (0.00), less than Diagnocure, Inc. (-0.00), less than NeonMind Biosciences Inc. (0), less than Generex Biotechnology Corporation (-0.00), less than Navidea Biopharmaceuticals, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $17.66K | |
| 0 | $22.77K | |
| 0 | $23.82K | |
| -0.01 | $17.66K | |
| 0 | $1.64K | |
| 0.00 | $2.09K | |
| -0.00 | $21.52K | |
| 0 | $8.54K | |
| -0.00 | $0 | |
| -0.00 | $10.01K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like QSAM Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like QSAM Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is QSAM Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for QSAM Biosciences, Inc. (QSAM)?
What is the highest PE Ratio for QSAM Biosciences, Inc. (QSAM)?
What is the 3-year average PE Ratio for QSAM Biosciences, Inc. (QSAM)?
What is the 5-year average PE Ratio for QSAM Biosciences, Inc. (QSAM)?
How does the current PE Ratio for QSAM Biosciences, Inc. (QSAM) compare to its historical average?